Guidance and advice published in September 2023, to include:

• New treatment for acute migraine set to benefit thousands
• Tirzepatide recommended as new treatment option for people with type 2 diabetes
• Share your views on transition from children’s to adults’ services quality standard
• Social Care: Social worker annual renewal period now open
• How to get access to the latest drug information quickly, offline and on-the-go
• Film a vlog for the World Evidence-Based Healthcare (EBHC) Day campaign

Read the full newsletter here.